Coronavirus (COVID-19): Information for TB Laboratories
CDC is providing updates on the current status of national tuberculosis (TB) laboratory services during the ongoing COVID-19 response efforts.
- CDC’s Molecular Detection of Drug Resistance (MDDR) Service is operational, and we are working diligently to ensure sufficient staffing and resources to provide both molecular and growth-based drug-susceptibility testing (DST). Turnaround times for issuance of reports back to submitters could be delayed. If you need additional information or have questions, please feel free to contact TBLab@cdc.gov or 404-639-2455.
No hay comentarios:
Publicar un comentario